Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate
- PMID: 4423432
- DOI: 10.1016/0090-4295(74)90013-2
Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate
Similar articles
-
Neurological manifestation of metastatic prostatic carcinoma.J Urol. 1974 Jun;111(6):799-802. doi: 10.1016/s0022-5347(17)60079-x. J Urol. 1974. PMID: 4830885 No abstract available.
-
Enlargement of the supraclavicular lymph nodes as the initial sign of prostatic carcinoma.Cancer. 1971 May;27(5):1055-63. doi: 10.1002/1097-0142(197105)27:5<1055::aid-cncr2820270509>3.0.co;2-t. Cancer. 1971. PMID: 5581507 No abstract available.
-
Orchiectomy for advanced prostatic carcinoma. A reevaluation.Urology. 1973 Jun;1(6):553-60. doi: 10.1016/0090-4295(73)90515-3. Urology. 1973. PMID: 4588820 Clinical Trial. No abstract available.
-
Current concepts concerning carcinoma of the prostate.Surg Annu. 1973;5:393-406. Surg Annu. 1973. PMID: 4602222 Review. No abstract available.
-
[Hormonal therapy of prostatic carcinoma].Internist (Berl). 1968 Sep;9(9):375-80. Internist (Berl). 1968. PMID: 4918657 Review. German. No abstract available.
Cited by
-
Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.Br J Cancer. 2005 Apr 25;92(8):1538-44. doi: 10.1038/sj.bjc.6602520. Br J Cancer. 2005. PMID: 15846301 Free PMC article.
-
Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882): an Eastern Cooperative Oncology Group study.Med Oncol. 2003;20(2):137-46. doi: 10.1385/MO:20:2:137. Med Oncol. 2003. PMID: 12835516 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources